Finance

Beta
Lists
AZTA:NASDAQ
Azenta Inc
$22.86
+0.59%
(+0.14) 1D
Jun 10, 1:05:26 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AZTA...
Open
$22.62
High
$23.22
Low
$22.47
Mkt. cap
1.05B
Avg. vol.
1.44M
Volume
255.52K
52-wk high
$41.73
52-wk low
$15.93
EPS
-$3.87
Beta
1.39
Shares outstanding
46.09M
No. of employees
3K
Open
$22.62
High
$23.22
Low
$22.47
Mkt. cap
1.05B
Avg. vol.
1.44M
Volume
255.52K
52-wk high
$41.73
52-wk low
$15.93
EPS
-$3.87
Beta
1.39
Shares outstanding
46.09M
No. of employees
3K
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to AZTA in the past 3 months
Strong Buy
Buy
3
Hold
1
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for AZTA in the last 3 months.
Highest
Current $22.86
$35.00 (+53.14%)
Average
$30.75 (+34.54%)
Lowest
$20.00 (-12.49%)
News stories
From sources across the web
Profile
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics. Wikipedia
About Azenta Inc
CEOJohn Marotta
Employees2.9K
Founded1978
HeadquartersBurlington, Massachusetts, United States
SectorHealth care
Websiteazenta.com
Last report
May 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.04 / $0.14
-128.99%miss
Revenue / Est. (USD)
144.80M / 148.47M
-2.47%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
143.94M
158.95M
148.64M
144.80M
Cost of goods sold
76.18M
90.99M
84.94M
82.76M
Cost of revenue
76.18M
90.99M
84.94M
82.76M
Research and development expenses
6.68M
10.46M
9.19M
9.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.04M
55.73M
60.61M
67.89M
Operating expense
67.72M
66.18M
69.80M
77.32M
Total operating expenses
143.90M
157.17M
154.74M
160.08M
Operating income
40.00K
1.78M
-6.09M
-15.28M
Other non operating income
-621.00K
2.18M
979.00K
801.00K
EBT including unusual items
3.44M
5.78M
-2.06M
-157.34M
EBT excluding unusual items
4.19M
8.28M
-917.00K
-10.70M
Income tax expense
2.76M
-45.61M
3.13M
-323.00K
Effective tax rate
80.22%
-789.61%
-151.94%
0.21%
Other operating expenses
-
-
-
-
Net income
-52.81M
50.84M
-15.43M
-160.80M
Net profit margin
-36.69%
31.98%
-10.38%
-111.05%
Earnings per share
0.19
0.21
0.09
-0.04
Interest and investment income
4.97M
5.02M
5.10M
4.39M
Interest expense
-
-
-
-
Net interest expenses
4.97M
5.02M
5.10M
4.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.76M
16.29M
7.55M
-1.28M
Gain or loss from assets sale
766.00K
93.07M
9.65M
6.33M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer